Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 5,022 | 5,663 | 5,004 | 4,002 | 4,931 |
| Cost of Goods | 2,204 | 1,945 | 2,382 | 3,356 | 3,341 |
| Gross Profit | 2,819 | 3,718 | 2,622 | 646 | 1,590 |
| Operating Expenses | 5,988 | 5,959 | 4,589 | 15,312 | 5,779 |
| Operating Income | -2,966 | -1,296 | -1,586 | -14,311 | -3,848 |
| Interest Expense | 2,951 | 2,107 | 1,662 | 2,482 | 1,625 |
| Other Income | 0 | 0 | 4 | -1,686 | 0 |
| Pre-tax Income | -5,917 | -3,403 | -3,244 | -18,479 | -5,473 |
| Income Tax | -1 | 4 | 4 | 5 | 5 |
| Net Income Continuous | -5,915 | -3,407 | -3,248 | -18,484 | -5,478 |
| Minority Interests | 4 | 10 | 10 | -49 | 7 |
| Net Income | $-5,919 | $-3,417 | $-3,258 | $-18,435 | $-5,485 |
| EPS Basic Total Ops | -0.06 | -0.03 | -0.03 | -0.19 | -0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.03 | -0.03 | -0.19 | -0.06 |
| EPS Diluted Total Ops | -0.06 | -0.03 | -0.03 | -0.19 | -0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.03 | -0.03 | -0.19 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.03 | -0.03 | -0.08 | -0.06 |
| EBITDA(a) | $-2,035 | $-353 | $-638 | $-12,303 | $-2,765 |